With the rapid advancements in gene therapy and sequencing technology, more rare disease pathogenesis and treatment methods are moving from bench to bedside. In this process, animal models play a pivotal role in disease pathogenesis studies, drug target identification, and drug efficacy evaluation. The Alliance has developed an array of rare disease mouse models, including gene knockout, knock-in, point mutation, and humanized mice. Contact Cyagen